Study finds Paxlovid treatment does not reduce risk of long COVID
byUniversity of California, San FranciscoIn all models, treatment with oral nirmatrelvir was not associated with lower odds of patient reported Long COVID symptoms with confidence intervals that
Updated on: January 26,2024
10

Study finds Paxlovid treatment does not reduce risk of long COVID
byUniversity of California, San FranciscoIn all models, treatment with oral nirmatrelvir was not associated with lower odds of patient reported Long COVID symptoms with confidence intervals that
Updated on:January 26,2024
10
